Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H18ClN5 |
Molecular Weight | 351.833 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
InChI
InChIKey=GJSLOMWRLALDCT-UHFFFAOYSA-N
InChI=1S/C19H18ClN5/c1-24(2)12-18-23-22-17-11-21-19(13-6-4-3-5-7-13)15-10-14(20)8-9-16(15)25(17)18/h3-10H,11-12H2,1-2H3
Adinazolam, a benzodiazepine agonist, is an effective anxiolytic agent with antidepressant properties. It was shown, that adinazolam by itself had relatively weak benzodiazepine agonist activity, and much of the pharmacological activity belonged to its active metabolite N-desmethyladinazolam (NDMAD). Adinazolam has never been FDA approved, but it is sold as a research chemical.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2109243 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6148400 |
PubMed
Title | Date | PubMed |
---|---|---|
Flumazenil prevents the anxiolytic effects of diazepam, alprazolam and adinazolam on the early acquisition of two-way active avoidance. | 1993 Jul-Aug |
|
Kinetic characterization and identification of the enzymes responsible for the hepatic biotransformation of adinazolam and N-desmethyladinazolam in man. | 1998 Mar |
|
The effect of sympathetic antagonists on the antidepressant action of alprazolam. | 2008 Jun 1 |
|
Recent trends in the impurity profile of pharmaceuticals. | 2010 Jul |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3298327
from 90 to 40 mg/day.
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QN05BA07
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
||
|
NCI_THESAURUS |
C1012
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
||
|
WHO-ATC |
N05BA07
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
||
|
WIKIPEDIA |
Designer-drugs-Adinazolam
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
KN08449444
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY | |||
|
37632
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY | |||
|
DTXSID40190611
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY | |||
|
ADINAZOLAM
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY | |||
|
100000087684
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY | |||
|
93
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY | |||
|
C76531
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY | |||
|
CHEMBL328250
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY | |||
|
m1418
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY | Merck Index | ||
|
4996
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY | |||
|
SUB05271MIG
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY | |||
|
C039668
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY | |||
|
251412
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY | |||
|
DB00546
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY | |||
|
37115-32-5
Created by
admin on Sat Dec 16 17:45:50 GMT 2023 , Edited by admin on Sat Dec 16 17:45:50 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)